Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Alison Martin(Frederick National Laboratory for Cancer Research), Ronald G. Steis, Jeanne B. Lawrence(University of Massachusetts Chan Medical School), Jeffrey W. Clark(Massachusetts General Hospital), Daniele Longo, Stacy Nerenstone, MJ Hawkins, Walter J. Urba(Providence Portland Medical Center), S P Creekmore, John W. Smith(SUNY Upstate Medical University)
Cited by 32
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k